Fujian Haixi (02637) Releases January 2026 Monthly Return with No Changes in Issued Shares
Bulletin Express
Feb 05
Fujian Haixi Pharmaceuticals Co., Ltd. (stock code: 02637) released its monthly return for the period ended January 31, 2026. According to the announcement, the total authorized share capital remained at RMB 78,707,270, with ordinary H shares accounting for 78,707,270 shares at RMB 1 each.
The number of fully issued shares—78,707,270—remained unchanged from the previous month, while there were no treasury shares. The company confirmed continued compliance with the applicable public float requirement. The announcement also indicated that there were no share options, warrants, convertible securities, or other arrangements to issue new shares during the reporting period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.